AKT1 and lung cancer: An increase in active Akt or its phosphorylation (pAkt) enhances the cell growth, cell survival and metastasis abilities of lung cancer, and the attenuation of Akt function has become a promising strategy for the research and development of anti-lung cancer therapies [12].